VXX-15418-35975 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-22
Dose 1 — Pfizer-BioNTech
2021-01-12
Registered in v-safe
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-12
Health check-in — day 0, dose 2
Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tiredness

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Chills, Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-14
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-01-15
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-28
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-16
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 42, dose 2
Feeling: Fair

Adult check-in
2021-04-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-14
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-10-09
Dose 3 — Pfizer-BioNTech
2021-10-11
Survey response — days 1–6 daily, dose 3
MedDRA: Axillary pain, Oedema peripheral — Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Axillary pain and swelling

MedDRA releases: 2024-11 · check-in free text available
2021-10-12
Survey response — days 1–6 daily, dose 3
MedDRA: Axillary pain, Oedema peripheral — Feeling: Fair · Site: Pain

Free text: Ipsilateral axillary pain and swelling

MedDRA releases: 2024-11 · check-in free text available
2021-10-13
Survey response — days 1–6 daily, dose 3
MedDRA: Axillary pain, Oedema peripheral — Feeling: Fair · Headache, Nausea · Be unable to work or attend school

Free text: Ipsilateral axillary pain and swelling

MedDRA releases: 2024-11 · check-in free text available
2021-10-16
Health check-in — day 7, dose 3
Feeling: Good · None

Adult check-in
2021-10-30
Health check-in — day 21, dose 3
Feeling: Good

Adult check-in
2021-11-13
Health check-in — day 35, dose 3
Feeling: Good

Adult check-in
2021-11-20
Health check-in — day 42, dose 3
Feeling: Good

Adult check-in
2022-01-08
Health check-in — 3 months, dose 3
Feeling: Good

Adult check-in
2022-04-09
Health check-in — 6 months, dose 3
Feeling: Fair

Adult check-in
2022-09-16
Dose 4 — Pfizer-BioNTech
2022-10-03
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-10-07
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-16
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-10-30
Health check-in — day 42, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-22	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech
3	2021-10-09	Pfizer-BioNTech	No
4	2022-09-16	Pfizer-BioNTech	No

Free text

Release 10 — days 1–6 daily, dose 3

2021-10-11

Systemic reaction (other): Axillary pain and swelling

2021-10-12

Systemic reaction (other): Ipsilateral axillary pain and swelling

2021-10-13

Systemic reaction (other): Ipsilateral axillary pain and swelling

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Axillary pain	·	·	✓
SRO	Oedema peripheral	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release